# Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study

> **NCT02632916** · PHASE2 · COMPLETED · sponsor: **Children's Hospital of Eastern Ontario** · enrollment: 10 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Zoledronic Acid
- **DRUG:** Denosumab

## Key facts

- **NCT ID:** NCT02632916
- **Lead sponsor:** Children's Hospital of Eastern Ontario
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2020-02-03
- **Final completion:** 2020-02-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632916, "Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02632916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*